Metabolic Testing Market, by Product Type (Metabolic Carts (Portable and Bench-top), Body Composition Analyzers (Portable and Bench-top), and ECGs/EKGs (Portable and Bench-top)), by Test Type (VO2 Max Analysis, RMR Analysis, and Body Composition Analysis), by End User (Hospitals & Clinics, Sports Performance Lab, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Metabolic testing devices are medical devices used to screen organ functions and disease conditions such as liver diseases, diabetes, kidney diseases, and cardiovascular diseases. Technologies involved in metabolic testing include VO2 (the amount (volume) of oxygen your body) Max analysis, RMR(Resting metabolic rate) analysis, and body composition analysis. VO2 Max analysis includes body’s maximum rate of oxygen consumption that is measured during incremental exercise. RMR analysis is resting metabolic rate analysis in which measurement of food and energy required to maintain basic body functions such as heartbeat, breathing, and maintenance of body heat is done. Body composition analysis consists of determination of ratio of different tissues of the body. Metabolic testing is helpful in lifestyle disease management, performance testing for sports and fitness professionals, and in case of metabolic disorders such as diabetes. Products available in market work on either of these technologies such as RMR, VO2 Max, and body consumption analysis. Commercially available products for metabolic testing include, ReeVue, Quark RMR w/CPET, Quark CPET, K5, and Ultima CardiO2.
Increasing approval from the US Food & Drug Administration is expected to boost the global metabolic testing market. These devices require 510 (k) premarket notification to be sold in market. For instance, on March 2020, K5 wearable metabolic system (K5 expands the scope of metabolic testing from clinical exercise testing to performance assessment.)had a 510 (k) premarket notification granted by the U.S. Food & Drug Administration (FDA) to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device (section 513(i)(1)(A) FD&C Act).
Market Dynamics
Increasing approval and launch of new products, high prevalence of lifestyle diseases, are expected to be major factors driving metabolic testing market growth. For instance, on August 5, 2022, COSMED srl, a metabolic company, introduced products such as Quark CPET (Cosmed srl) with multiple configurations such as ECG testing and nutritional assessment and products such as ReeVue (Korr Medical Technologies Inc.) with mixing chamber technology, self-calibration, and reimbursement facility.
Prevalence of lifestyle diseases is high in key regions. Lifestyle diseases can lead to metabolic diseases which in turn is expected to drive demand for metabolic testing devices and drive metabolic testing market growth. For instance, on July 7, 2022, the state of food and and Nutrition in the World, published 2022 report on obesity, which stated that the prevalence of obesity in India’s adult population increased to 3.9 per cent in 2016 from 3.1 per cent in 2012 and anaemic women aged 15 to 49 years declined marginally from 53.2 per cent in 2012 to 53 per cent in 2019.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook